Data Papers

Data Paper
Pilot Study of the Antitumor Efficacy and Tolerability of Orally Administered Rrx-001 in Normal and Tumor-Bearing Mice
Ning S, Oronsky B, Scicinski J, Carter C, Knox S.
J Cancer Res Therap Oncol 4: 1-6. September 18, 2018.

Data Paper
Platelet inhibitory effects of the Phase 3 anticancer and normal tissue cytoprotective agent, RRx-001
Oronsky B, Oronsky N, Cabrales P.
J Cell Mol Med. 2018 Jul 16. doi: 10.1111/jcmm.13791

Data Paper
Magnetic resonance imaging of RRx-001 pharmacodynamics in preclinical tumors.
Raghunand N, Scicinski J, Guntle G, Jagadish B, Mash E, Bruckheimer E, Oronsky B, Korn R.
Oncotarget. 2017 Jun 12;8(60):102511-102520. doi: 10.18632/oncotarget.18455. eCollection 2017 Nov 24.

Data Paper
Epigenetic approaches to overcoming chemotherapy resistance
Strauss J, Figg W.
Lancet Oncol. 2015 Sep;16(9) 1013-1015